<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00298597</url>
  </required_header>
  <id_info>
    <org_study_id>GCSFEPO_01</org_study_id>
    <secondary_id>EudraCT Number 2005-001113-18</secondary_id>
    <nct_id>NCT00298597</nct_id>
  </id_info>
  <brief_title>Influence of G-CSF and EPO on Associative Learning and Motor Skills</brief_title>
  <official_title>Influence of G-CSF and EPO on Associative Learning and Motor Skills</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Muenster</source>
  <brief_summary>
    <textblock>
      In the study we want to prove whether the subcutaneous application of granulocyte-stimulating
      factor (G-CSF) and erythropoetin (EPO) influence associative learning and/or motor skills of
      patients, who suffer from chronic stroke or amyotrophic lateral sclerosis. The study
      hypothesis is that G-CSF and EPO improve associative learning and/or motor skills.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2006</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Learning success in a word learning model</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Response time in motor function tests</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Response time in a word learning model</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total time and number of keystrokes in motor function tests</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Chronic Stroke</condition>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>granulocyte - colony stimulating factor (G-CSF)</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>erythropoetin (EPO)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of chronic stroke or amyotrophic lateral sclerosis

        Exclusion Criteria:

          -  leucocytes &gt; 10000/µl

          -  hematocrit &gt; 48%

          -  thrombocytes &lt; 150000/µl

          -  severe rheumatoid arthritis

          -  severe infection

          -  severe liver or renal failure

          -  severe arterial hypertension

          -  recurrent thromboembolic events

          -  severe coronary heart disease

          -  myocardial infarction

          -  malignant tumor

          -  leukemia

          -  peripheral arterial occlusion disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wolf Rüdiger Schäbitz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurology, University Hospital of Muenster, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of neurology, University Hospital of Muenster</name>
      <address>
        <city>Muenster</city>
        <state>Nordrhein-Westfalen</state>
        <zip>D-48149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Knecht S, Breitenstein C, Bushuven S, Wailke S, Kamping S, Flöel A, Zwitserlood P, Ringelstein EB. Levodopa: faster and better word learning in normal humans. Ann Neurol. 2004 Jul;56(1):20-6.</citation>
    <PMID>15236398</PMID>
  </reference>
  <reference>
    <citation>Schneider A, Kuhn HG, Schäbitz WR. A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle. 2005 Dec;4(12):1753-7. Epub 2005 Dec 27. Review.</citation>
    <PMID>16258290</PMID>
  </reference>
  <reference>
    <citation>Schneider A, Krüger C, Steigleder T, Weber D, Pitzer C, Laage R, Aronowski J, Maurer MH, Gassler N, Mier W, Hasselblatt M, Kollmar R, Schwab S, Sommer C, Bach A, Kuhn HG, Schäbitz WR. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest. 2005 Aug;115(8):2083-98. Epub 2005 Jul 7.</citation>
    <PMID>16007267</PMID>
  </reference>
  <verification_date>April 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2006</study_first_submitted>
  <study_first_submitted_qc>March 1, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2006</study_first_posted>
  <last_update_submitted>April 22, 2009</last_update_submitted>
  <last_update_submitted_qc>April 22, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 23, 2009</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epoetin Alfa</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

